Abstract Renal cell cancer (RCC) most commonly metastasizes to the lungs, bones, liver, renal fossa, and brain, although metastases can occur elsewhere. RCC metastatic to the duodenum is especially rare, with only a small number of cases reported in the literature. Herein, we describe a case of an 86-year-old woman with a history of RCC treated by radical nephrectomy 13 years previously. The patient presented with duodenal obstruction and anemia from a solitary duodenal mass invading into the pancreas and was treated via classic pancreaticoduodenectomy. Preoperative imaging and intraoperative assessment showed no evidence of other disease. Pathology confirmed metastatic RCC without lymph node involvement. Our case report and review of the English language literature underscore the rarity of this entity and support aggressive surgical treatment in such patients.
Introduction
Renal cell carcinoma (RCC) commonly metastasizes to sites such as lung, lymph nodes, liver, pancreas, bone, brain, contralateral kidney, and adrenal glands. 1 Autopsy studies have shown that metastatic disease of any type to the small intestine is unusual and accounts for only 1-2% of all metastases. Approximately 7% of small bowel metastatic lesions is of renal cell origin. 2 RCC metastatic to the pancreas has been frequently reported. [3] [4] [5] Solitary metastasis from RCC to the duodenum is exceedingly rare.
Commonly, renal cell metastases present many years after initial treatment, with recurrences reported up to 17.5 years after initial surgery. 6 Most cases of duodenal metastasis from RCC present with upper gastrointestinal bleeding or obstructive symptoms, and sequelae may include anemia, melena, fatigue, and early satiety. Several treatments of solitary RCC metastasis have been reported. These include a variety of surgical and interventional therapy options that have been shown to provide effective survival benefits. Herein, we report a case of an 86 year-old woman with metastatic RCC confined to the duodenum, with successful complete resection by classic pancreaticoduodenectomy.
Clinical Material
An 86-year-old woman with a past medical history notable for hypertension and RCC, 13 years status, post-right radical nephrectomy, presented to her primary care physician with fatigue. When found to be anemic, she was treated with iron supplementation. Several months later, she continued to have fatigue, anorexia, early satiety, and weight loss of approximately 6 lb and was found to have heme-positive stools. Jaundice and pancreatitis were absent. The patient underwent a capsule endoscopy; however, the capsule never left the stomach. The patient then had an esophagogastroduodeno-scopy, which showed an ulcerated mass involving the distal antrum and proximal duodenum. Biopsy of the ulcerated mass was consistent with metastatic RCC. An abdominal computed tomography (CT) scan (Fig. 1) showed a large soft tissue mass at the level of the gastric antrum and duodenal bulb, no evidence of liver metastasis, and her visceral vessels appeared normal. She was scheduled for surgical resection and received perioperative prophylactic antibiotic, subcutaneous heparin, and sequential compression devices.
At the time of operation, exploration of the duodenum and head of the pancreas revealed a mass clearly located in the proximal duodenum with involvement of the head of the pancreas and distal antrum. There was no evidence of malignant ascites, carcinomatosis, omental implants, or involvement of the liver. Attempts were made to dissect the tumor free of the head of the pancreas; however, the duodenal mass was adherent to and invading into the pancreas. A classic Whipple procedure was performed, and the resultant specimen was sent for pathologic evaluation. Postoperatively, the patient's hospital course was complicated by hypoxemia and bilobar pulmonary emboli treated with appropriate anticoagulation. Ultimately, the patient was discharged to a rehabilitation facility on postoperative day 16 in stable condition, doing well. In follow-up, the patient is leading an active life and continues to do well, now 7 months after resection, without evidence of further metastatic disease.
Pathology
Gross examination of the classic pancreaticoduodenectomy specimen revealed a 9×5.5×3-cm tan-red polypoid, pedunculated tumor protruding into the duodenum (Fig. 2) . The tumor involved the full thickness of duodenal wall and invaded into the pancreatic head (Figs. 3 and 4) . Microscopically, the tumor was composed of clear cells arranged in a trabecular and alveolar pattern. The tumor cells had centrally located small nuclei with inconspicuous nucleoli and were surrounded by a prominent vascular network (Fig. 5) . Eight lymph nodes were identified in the resection specimen, and all were negative for metastatic tumor.
Discussion
Metastatic RCC to the duodenum is extremely rare. For the purposes of this report, we have included patients with the bulk of the gross tumor in the duodenal or ampullary regions, distinct from pancreatic involvement. Our review of the English language literature (using keywords including: RCC, solitary, metastasis, duodenum and ampulla) yielded 16 reports of solitary duodenal/ampullary renal cell metastases ( Table 1 ). The mean time period from nephrectomy to Figure 5 The tumor was composed of clear cells arranged in trabecular and alveolar patterns. The tumor cells had centrally located small nuclei with inconspicuous nucleoli, and were surrounded by a prominent vascular network (hematoxylin and eosin, ×400 magnification). diagnosis of these solitary metastases was 8 years, with our patient having a 13-year interval between initial resection and recurrence. The most common presentation of these patients was gastrointestinal bleeding (69%), whereas a minority presented with pain, jaundice, or early satiety. RCC can spread via lymphatic or hematogenous spread, as well as by direct invasion into adjacent anatomic structures. 7 The pancreas is an unusual site of metastatic disease for other tumors, but it is common in RCC. The duodenum is a particularly rare site of metastasis in RCC, which is perhaps counterintuitive given its retroperitoneal proximity to the right kidney.
The natural history of RCC is unpredictable. Disease eradication and cure are possible after nephrectomy; however, there is also the possibility of a long period of disease latency, followed by recurrence of metastatic disease at unsuspected anatomic locations. 1 As such, it is imperative to remain vigilant in post-nephrectomy patients upon presentation of new clinical symptoms. When metastatic RCC involves the duodenum, it most commonly is located in the periampullary region or the duodenal bulb. 8 The presenting symptoms in these rare cases typically include gastrointestinal bleeding, anemia, fatigue, and obstruction with early satiety or jaundice. Our patient initially presented with fatigue and was found to be anemic with heme-positive stools. Any patient with gastrointestinal symptoms and a history of RCC should undergo full diagnostic work-up with both radiologic and endoscopic evaluation. 9 Endoscopy allows for biopsy of suspicious lesions and is mandatory for this subset of patients.
Surgical treatment of solitary RCC metastasis has been shown to improve survival. [3] [4] [5] 10, 11 Therapeutic goals include complete metastatectomy whenever surgically feasible. Several case series have been reported of successful surgical treatment of solitary pancreatic RCC metastases 3, 4 ; however, few isolated reports of excision of duodenal or ampullary metastases exist in the literature. Procedures ranging from classic pancreaticoduodenectomy (Whipple procedure) to interventional embolization have been reported (Table 1 ). In patients with massive gastrointestinal bleeding secondary to metastatic duodenal RCC, arteriography with embolization of the gastroduodenal artery has been described. 12 Our patient had isolated proximal duodenal involvement with adherence to the head of the pancreas making it impossible to separate the duodenal/ pancreatic border. Thus, given the involvement of the mass with the proximal duodenum, a classic pancreaticoduodenectomy was performed, with successful excision of all involved structures with clear margins and with no lymph node involvement. In fact, all resection specimens from all reviewed case reports have revealed no lymph node involvement (Table 1) .
In summary, solitary metastatic RCC to the duodenum is extremely rare. Appropriate awareness and aggressive workup of gastrointestinal symptoms in patients post-nephrectomy for RCC are of paramount importance. In this subgroup of patients with symptoms of gastrointestinal bleeding, fatigue, anemia, and early satiety or obstruction, all should undergo complete endoscopic evaluation, as well as radiologic investigation to evaluate for the presence of and the extent of metastatic disease. Any patient with solitary metastatic RCC to the duodenum should be considered a candidate for complete surgical excision if medically and technically feasible, both for palliation of symptoms and because it provides the opportunity for meaningful disease free survival.
